{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:41:37Z","timestamp":1790635297969,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81874137"],"award-info":[{"award-number":["81874137"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The long noncoding RNA, <jats:italic>LINC00518<\/jats:italic>, is highly expressed in various types of cancers and is involved in cancer progression. Although <jats:italic>LINC00518<\/jats:italic> promotes the metastasis of cutaneous malignant melanoma (CMM), the mechanism underlaying its effects on CMM radiosensitivity remains unclear. In this study, <jats:italic>LINC00518<\/jats:italic> expression was significantly upregulated in CMM samples, and <jats:italic>LINC00518<\/jats:italic> levels were associated with poor prognosis of patients with CMM. Knockdown of <jats:italic>LINC00518<\/jats:italic> in CMM cells significantly inhibited cell invasion, migration, proliferation, and clonogenicity. LINC00518-mediated invasion, migration, proliferation, and clonogenicity were negatively regulated by the microRNA, miR-33a-3p, in vitro, which increased sensitivity to radiotherapy via inhibition of the hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1)\/lactate dehydrogenase A glycolysis axis. Additionally, HIF-1\u03b1 recognized the miR-33a-3p promoter region and recruited histone deacetylase 2, which decreased the expression of miR-33a-3p and formed an <jats:italic>LINC00518<\/jats:italic>\/miR-33a-3p\/HIF-1\u03b1 negative feedback loop. Furthermore, signaling with initially activated glycolysis and radioresistance in CMM cells was impaired by Santacruzamate A, a histone deacetylase inhibitor, and 2-deoxy-D-glucose, a glycolytic inhibitor. Lastly, knockdown of <jats:italic>LINC00518<\/jats:italic> expression sensitized CMM cancer cells to radiotherapy in an in vivo subcutaneously implanted tumor model. In conclusion, <jats:italic>LINC00518<\/jats:italic> was confirmed to be an oncogene in CMM, which induces radioresistance by regulating glycolysis through an miR-33a-3p\/HIF-1\u03b1 negative feedback loop. Our study, may provide a potential strategy to improve the treatment outcome of radiotherapy in CMM.<\/jats:p>","DOI":"10.1038\/s41419-021-03523-z","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T14:02:56Z","timestamp":1614866576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p\/HIF-1\u03b1 negative feedback loop in melanoma"],"prefix":"10.1038","volume":"12","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-2306","authenticated-orcid":false,"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"3523_CR1","first-page":"1","volume":"1","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf, D. et al. Melanoma. Nat. Rev. Dis. 1, 1\u201320 (2015).","journal-title":"Nat. Rev. Dis."},{"key":"3523_CR2","first-page":"1005","volume":"28","author":"M Rastrelli","year":"2014","unstructured":"Rastrelli, M., Tropea, S., Rossi, C. & Alaibac, M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo 28, 1005\u20131011 (2014).","journal-title":"In Vivo"},{"key":"3523_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/phar.1895","volume":"37","author":"C Lee","year":"2017","unstructured":"Lee, C., Thoma, C. & Ng, K. An overview of the changing landscape of treatment for advanced melanoma. Pharmacotherapy 37, 319\u2013333 (2017).","journal-title":"Pharmacotherapy"},{"key":"3523_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"A Eggermont","year":"2014","unstructured":"Eggermont, A., Spatz, A. & Robert, C. Cutaneous melanoma. Lancet 383, 816\u2013827 (2014).","journal-title":"Lancet"},{"key":"3523_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"C Balch","year":"2009","unstructured":"Balch, C., Gershenwald, J., Soong, S., Thompson, J. & Atkins, M. Final version of 2009 AJCC melanoma staging and classification. J. Clin. Oncol. 27, 199\u20136206 (2009).","journal-title":"J. Clin. Oncol."},{"key":"3523_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/0284186X.2017.1295168","volume":"56","author":"W Mendenhall","year":"2017","unstructured":"Mendenhall, W. et al. Adjuvant postoperative radiotherapy for cutaneous melanoma. Acta Oncol. 56, 495\u2013496 (2017).","journal-title":"Acta Oncol."},{"key":"3523_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.ijrobp.2008.06.1910","volume":"73","author":"B Beadle","year":"2009","unstructured":"Beadle, B. et al. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma. Int. J. Radiat. Oncol. Biol. Phys. 73, 1376\u20131382 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"3523_CR8","first-page":"743","volume":"29","author":"A Mahadevan","year":"2015","unstructured":"Mahadevan, A., Patel, V. & Dagoglu, N. Radiation therapy in the management of malignant melanoma. Oncology 29, 743\u2013751 (2015).","journal-title":"Oncology"},{"key":"3523_CR9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.2340\/00015555-2035","volume":"95","author":"E Maverakis","year":"2015","unstructured":"Maverakis, E., Cornelius, L., Bowen, G., Phan, T. & Patel, F. B. Metastatic melanoma\u2014a review of current and future treatment options. Acta Derm. Venereol. 95, 516\u2013524 (2015).","journal-title":"Acta Derm. Venereol."},{"key":"3523_CR10","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nrc3726","volume":"14","author":"D Gilkes","year":"2014","unstructured":"Gilkes, D., Semenza, G. & Wirtz, D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer 14, 430\u2013439 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"3523_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"H Barker","year":"2015","unstructured":"Barker, H., Paget, J., Khan, A. & Harrington, K. The tumour microenvironmentafter radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409\u2013425 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"3523_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.placenta.2017.03.010","volume":"56","author":"P Macklin","year":"2017","unstructured":"Macklin, P., McAuliffe, J., Pugh, C. & Yamamoto, A. Hypoxia and HIF pathway in cancer and the placenta. Placenta 56, 8\u201313 (2017).","journal-title":"Placenta"},{"key":"3523_CR13","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1113\/JP273309","volume":"595","author":"S Parks","year":"2017","unstructured":"Parks, S., Cormerais, Y. & Pouyss\u00e9gur, J. Hypoxia and cellular metabolism in tumour pathophysiology. J. Physiol. 595, 2439\u20132450 (2017).","journal-title":"J. Physiol."},{"key":"3523_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"3523_CR15","first-page":"1","volume":"1816","author":"K Nys","year":"2011","unstructured":"Nys, K., Maes, H., Dudek, A. & Agostinis, P. Uncovering the role of hypoxia inducible factor-1alpha in skin carcinogenesis. Biochim. Piophys. Acta 1816, 1\u201312 (2011).","journal-title":"Biochim. Piophys. Acta"},{"key":"3523_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ejca.2010.01.031","volume":"46","author":"S Kuphal","year":"2010","unstructured":"Kuphal, S., Winklmeier, A., Warnecke, C. & Bosserhoff, A. Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer 46, 1159\u20131169 (2010).","journal-title":"Eur. J. Cancer"},{"key":"3523_CR17","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1128\/MCB.06120-11","volume":"31","author":"J Fan","year":"2011","unstructured":"Fan, J. et al. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH\/NAD(+) redox homeostasis in cancer cells. Mol. Cell Biol. 31, 4938\u20134950 (2011).","journal-title":"Mol. Cell Biol."},{"key":"3523_CR18","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke, Q. & Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469\u20131480 (2006).","journal-title":"Mol. Pharmacol."},{"key":"3523_CR19","doi-asserted-by":"publisher","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","volume":"18","author":"T Meijer","year":"2012","unstructured":"Meijer, T., Kaanders, J., Span, P. & Bussink, J. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. Clin. Cancer Res. 18, 5585\u20135594 (2012).","journal-title":"Clin. Cancer Res."},{"key":"3523_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","volume":"77","author":"F Zhao","year":"2016","unstructured":"Zhao, F., Ming, J., Zhou, Y. & Fan, L. Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother. Pharmacol. 77, 963\u2013972 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"3523_CR21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.radonc.2014.07.015","volume":"112","author":"T Shimura","year":"2014","unstructured":"Shimura, T. et al. AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells. Radiother. Oncol. 112, 302\u2013307 (2014).","journal-title":"Radiother. Oncol."},{"key":"3523_CR22","first-page":"4054","volume":"8","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. HK2 is a radiation resistant and independent negative prognostic factor for patients with locally advanced cervical squamous cell carcinoma. Int. J. Clin. Exp. Pathol. 8, 4054\u20134063 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"3523_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"J Quinn","year":"2016","unstructured":"Quinn, J. & Chang, H. Unique features of\u2002long non-coding RNA\u2002biogenesis and function. Nat. Rev. Genet. 17, 47\u201362 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"3523_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","volume":"1008","author":"J Jarroux","year":"2017","unstructured":"Jarroux, J., Morillon, A. & Pinskaya, M. History, discovery, and classification of lncRNAs. Adv. Exp. Med. Biol. 1008, 1\u201346 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"3523_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1073\/pnas.1711257115","volume":"115","author":"S Xiang","year":"2018","unstructured":"Xiang, S. et al. LncRNA IDH1-AS1 links the functions of c-Myc and HIF-1\u03b1 via IDH1 to regulate the Warburg effect. Proc. Natl Acad. Sci. USA 115, 1465\u20131474 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3523_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2013.11.004","volume":"53","author":"F Yang","year":"2014","unstructured":"Yang, F., Zhang, H., Mei, Y. & Wu, M. Reciprocal regulation of HIF-1\u03b1 and LINCRNA-p21 modulates the Warburg effect. Mol. Cell. 53, 88\u2013100 (2014).","journal-title":"Mol. Cell."},{"key":"3523_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"S Leonardo","year":"2011","unstructured":"Leonardo, S., Laura, P., Yvonne, T., Lev, K. & Pier, P. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146, 353\u2013358 (2011).","journal-title":"Cell"},{"key":"3523_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.15252\/embr.201642067","volume":"17","author":"P Zhang","year":"2016","unstructured":"Zhang, P., Cao, L., Fan, P., Mei, Y. & Wu, M. LncRNA-MIF, a c-Myc-activated long non-coding RNA, suppresses glycolysis by promoting Fbxw7-mediated c-Myc degradation. EMBO Rep. 17, 1204\u20131220 (2016).","journal-title":"EMBO Rep."},{"key":"3523_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/hep.29462","volume":"67","author":"Y Lin","year":"2018","unstructured":"Lin, Y. et al. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology 67, 188\u2013203 (2018).","journal-title":"Hepatology"},{"key":"3523_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/pcmr.12537","volume":"29","author":"E Leucci","year":"2016","unstructured":"Leucci, E., Coe, E., Marine, J. & Vance, K. The emerging role of long non-coding RNAs in cutaneous melanoma. Pigment Cell Melanoma Res. 29, 619\u2013626 (2016).","journal-title":"Pigment Cell Melanoma Res."},{"key":"3523_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1371\/journal.pone.0010770","volume":"5","author":"O Kabbarah","year":"2010","unstructured":"Kabbarah, O. et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 5, 5\u20132 (2010).","journal-title":"PLoS ONE"},{"key":"3523_CR32","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.4161\/cbt.4.9.2165","volume":"4","author":"A Smith","year":"2005","unstructured":"Smith, A., Hoek, K. & Becker, D. Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi\/melanoma in situ and advanced-stage melanomas. Cancer Biol. Ther. 4, 1018\u20131029 (2005).","journal-title":"Cancer Biol. Ther."},{"key":"3523_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41419-019-2090-3","volume":"10","author":"W Luan","year":"2019","unstructured":"Luan, W. et al. Long noncoding RNA LINC00518 acts as a competing endogenous RNA to promote the metastasis of malignant melanoma via miR-204-5p\/AP1S2 axis. Cell Death Dis. 10, 855\u2013867 (2019).","journal-title":"Cell Death Dis."},{"key":"3523_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CMR.0000000000000035","volume":"24","author":"S Oliveira","year":"2014","unstructured":"Oliveira, S., Yang, L., Echevarria-Lima, J., Monteiro, R. Q. & Rezaie, A. R. Thrombomodulin modulates cell migration in human melanoma cell lines. Melanoma Res. 24, 11\u201319 (2014).","journal-title":"Melanoma Res."},{"key":"3523_CR35","first-page":"4349","volume":"19","author":"Z Wang","year":"1999","unstructured":"Wang, Z. et al. Association of EGFR gene fragments with nuclear matrix proteins in high and low metastatic melanoma cell lines. Anticancer Res. 19, 4349\u20134352 (1999).","journal-title":"Anticancer Res."},{"key":"3523_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000491659","volume":"48","author":"L Chang","year":"2018","unstructured":"Chang, L., Hu, Z., Zhou, Z. & Zhang, H. Linc00518\u2002contributes to multidrug resistance through regulating the MiR-199a\/MRP1 axis in breast cancer. Cell Physiol. Biochem. 48, 16\u201328 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"3523_CR37","first-page":"496","volume":"23","author":"D Wang","year":"2019","unstructured":"Wang, D., You, D., Dong, J. & Liu, F. Knockdown of long non-coding RNA LINC00518\u2002inhibits cervical cancer proliferation and metastasis by modulating JAK\/STAT3 signaling. Eur. Rev. Med. Pharm. Sci. 23, 496\u2013506 (2019).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"3523_CR38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/15384047.2015.1030545","volume":"16","author":"J Zhou","year":"2015","unstructured":"Zhou, J. et al. MiR-33a\u2002functions\u2002as a tumor suppressor in melanoma by targeting HIF-1\u03b1. Cancer Biol. Ther. 16, 846\u2013855 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"3523_CR39","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary, C. et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834\u2013840 (2009).","journal-title":"Science"},{"key":"3523_CR40","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1172\/JCI30269","volume":"117","author":"C Magnon","year":"2007","unstructured":"Magnon, C., Opolon, P. & Schlumberger, M. Radiation and inhibition of angiogenesis by canstatin synergize to induce\u2002HIF-1alpha-mediated tumor apoptotic switch. J. Clin. Invest. 117, 1844\u20131855 (2007).","journal-title":"J. Clin. Invest."},{"key":"3523_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jaad.2016.07.038","volume":"76","author":"P Gerami","year":"2017","unstructured":"Gerami, P. et al. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma. J. Am. Acad. Dermatol. 76, 114\u2013120 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"3523_CR42","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamadermatol.2017.0473","volume":"153","author":"L Ferris","year":"2017","unstructured":"Ferris, L. et al. Utility of a noninvasive 2-gene molecular assay for cutaneous melanoma and effect on the decision to biopsy. JAMA Dermatol. 153, 675\u2013680 (2017).","journal-title":"JAMA Dermatol."},{"key":"3523_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.7150\/jca.17510","volume":"8","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. J. Cancer 8, 523\u2013530 (2017).","journal-title":"J. Cancer"},{"key":"3523_CR44","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1038\/s41388-019-0858-7","volume":"38","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y. et al. The MRVI1-AS1\/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway. Oncogene 38, 6065\u20136081 (2019).","journal-title":"Oncogene"},{"key":"3523_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of\u2002ceRNA\u2002crosstalk and competition. Nature 505, 344\u2013352 (2014).","journal-title":"Nature"},{"key":"3523_CR46","doi-asserted-by":"crossref","unstructured":"Qi, X. et al. CeRNA\u2002in cancer: possible functions and clinical implications. J. Med. Genet. 52, 710\u2013718 (510).","DOI":"10.1136\/jmedgenet-2015-103334"},{"key":"3523_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.gpb.2017.02.003","volume":"15","author":"H Chen","year":"2017","unstructured":"Chen, H., Du, G., Song, X. & Li, L. Non-coding transcripts from enhancers: new insights into enhancer activity and gene expression regulation. Genom. Proteom. Bioinform. 15, 201\u2013207 (2017).","journal-title":"Genom. Proteom. Bioinform."},{"key":"3523_CR48","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2015.02.002","volume":"21","author":"A Moussaieff","year":"2015","unstructured":"Moussaieff, A., Rouleau, M., Aberdam, D. & Nahmias, Y. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392\u2013402 (2015).","journal-title":"Cell Metab."},{"key":"3523_CR49","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1093\/nar\/gkw1247","volume":"45","author":"E Zhang","year":"2017","unstructured":"Zhang, E., Han, L., Yin, D., Shu, Y. & Chen, J. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma. Nucleic Acids Res. 45, 3086\u20133101 (2017).","journal-title":"Nucleic Acids Res."},{"key":"3523_CR50","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/jbmr.2787","volume":"31","author":"Z Schoepflin","year":"2016","unstructured":"Schoepflin, Z., Shapiro, I. & Risbud, M. Class I. and IIa HDACs mediate HIF-1\u03b1 stability through PHD2-dependent mechanism, while HDAC6, a class IIb member, promotes HIF-1\u03b1 transcriptional activity in nucleus pulposus cells of the intervertebral disc. J. Bone Miner. Res. 31, 1287\u20131299 (2016).","journal-title":"J. Bone Miner. Res."},{"key":"3523_CR51","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/0008-5472.CAN-15-2680","volume":"76","author":"A Krumm","year":"2016","unstructured":"Krumm, A. et al. Enhanced histone deacetylase activity in malignant melanoma provokes RAD51 and FANCD2-triggered drug resistance. Cancer Res. 76, 3067\u20133077 (2016).","journal-title":"Cancer Res."},{"key":"3523_CR52","doi-asserted-by":"publisher","first-page":"42461","DOI":"10.18632\/oncotarget.9886","volume":"7","author":"S Han","year":"2016","unstructured":"Han, S. et al. MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma. Oncotarget 7, 42461\u201342473 (2016).","journal-title":"Oncotarget"},{"key":"3523_CR53","first-page":"623","volume":"39","author":"M Liang","year":"2019","unstructured":"Liang, M., Liu, Z., Lin, H., Shi, B. & Li, M. Chen T. High-throughput sequencing reveals circular RNA hsa_circ_0000592 as a novel player in the carcinogenesis of gastric carcinoma. Biosci. Rep. 39, 623\u2013641 (2019).","journal-title":"Biosci. Rep."},{"key":"3523_CR54","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s13187-013-0486-9","volume":"28","author":"M Akram","year":"2013","unstructured":"Akram, M. et al. Mini-review on glycolysis and cancer. J. Cancer Educ. 28, 454\u2013457 (2013).","journal-title":"J. Cancer Educ."},{"key":"3523_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1476-4598-12-52","volume":"12","author":"S Ganapathy","year":"2013","unstructured":"Ganapathy, S. & Geschwind, J. Tumor\u2002glycolysis\u2002as a target for cancer therapy: progress and prospects. Mol. Cancer 12, 52\u2013159 (2013).","journal-title":"Mol. Cancer"},{"key":"3523_CR56","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.redox.2015.08.016","volume":"6","author":"A G\u00f6rlach","year":"2015","unstructured":"G\u00f6rlach, A., Dimova, E., Petry, A. & Mart\u00ednez-Ruiz, A. Reactive oxygen species, nutrition,\u2002hypoxia\u2002and diseases: problems solved? Redox Biol. 6, 372\u2013385 (2015).","journal-title":"Redox Biol."},{"key":"3523_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/ijms18102050","volume":"18","author":"N Nosrati","year":"2017","unstructured":"Nosrati, N., Bakovic, M. & Paliyath, G. Molecular mechanisms and pathways as targets for cancer prevention and progression with dietary compounds. Int. J. Mol. Sci. 18, 57\u201363 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"3523_CR58","doi-asserted-by":"publisher","first-page":"e962","DOI":"10.1111\/j.1365-2230.2009.03706.x","volume":"34","author":"J Valencak","year":"2009","unstructured":"Valencak, J., Kittler, H. & Gonzalez-Inchaurraga, M. Prognostic relevance of hypoxia inducible factor-1alpha expression in patients with melanoma. Clin. Exp. Dermatol. 34, e962\u2013e964 (2009).","journal-title":"Clin. Exp. Dermatol."},{"key":"3523_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1158\/1078-0432.CCR-17-0419","volume":"24","author":"Q Zeng","year":"2018","unstructured":"Zeng, Q. et al. Inhibition of REDD1 sensitizes bladder urothelial carcinoma to paclitaxel by inhibiting autophagy. Clin. Cancer Res. 24, 445\u2013459 (2018).","journal-title":"Clin. Cancer Res."},{"key":"3523_CR60","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1158\/0008-5472.CAN-13-0913","volume":"73","author":"W Li","year":"2013","unstructured":"Li, W. et al. TRAF4 is a critical molecule for Akt activation in lung cancer. Cancer Res. 73, 6938\u20136950 (2013).","journal-title":"Cancer Res."},{"key":"3523_CR61","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/nprot.2006.339","volume":"5","author":"NA Franken","year":"2006","unstructured":"Franken, N. A., Rodermond, H. M., Stap, J., Haveman, J. & van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 5, 2315\u20132319 (2006).","journal-title":"Nat. Protoc."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03523-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03523-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03523-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:34:30Z","timestamp":1669919670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03523-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["3523"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03523-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"16 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The design and methods of the research are in accordance with the requirements of related and procedures (such as Ethical Review of Biomedical Research involving Human Subject, ICH-GCP) as well as the ethical principles. The study was performed in accordance with the Declaration of Helsinki. The IRB of The Third Xiangya Hospital of Central South University has approved the research to be conducted. The Number of approval for scientific research project is: No. 2019-S493.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"245"}}